Biotechnology - Paris, Île-de-France, France
The company is a STERIX "Contract Research Organization" dedicated in evaluating and optimizing the use of antibiotics. It offers to its customers and partners the opportunity to test: - New molecules before placing on the market. - Molecules are already sold, for which an update of data is necessitated by the changing epidemiology and bacterial resistance.